# The Optimal Head Position for Distributing Topical Nasal Medication Using the Mucosal Atomization Device

> **NCT02079792** · PHASE4 · COMPLETED · sponsor: **St. Paul's Hospital, Canada** · enrollment: 66 (actual)

## Conditions studied

- Sinusitis

## Interventions

- **PROCEDURE:** Lying Head Back Position
- **PROCEDURE:** Head Down and Forward Position

## Key facts

- **NCT ID:** NCT02079792
- **Lead sponsor:** St. Paul's Hospital, Canada
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-06
- **Final completion:** 2015-08
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2016-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02079792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02079792, "The Optimal Head Position for Distributing Topical Nasal Medication Using the Mucosal Atomization Device". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02079792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*